Chemistry:Revaprazan
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Revanex[1] |
| Other names | YH1885 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C22H23FN4 |
| Molar mass | 362.452 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Revaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis.[2] It acts as an acid pump antagonist[3] (potassium-competitive acid blocker). Revaprazan is approved for use in South Korea,[4] but is not approved in Europe or the United States.
References
- ↑ "Revaprazan". drugs.com. https://www.drugs.com/international/revaprazan.html.
- ↑ "Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects". J Gastroenterol Hepatol 25 (10): 1618–1625. Oct 2010. doi:10.1111/j.1440-1746.2010.06408.x. PMID 20880169.
- ↑ "Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers". J Clin Pharmacol 44 (1): 73–82. Jan 2004. doi:10.1177/0091270003261321. PMID 14681344.
- ↑ "Revaprazan Yuhan registered, South Korea (gastritis)". R & D Focus Drug News. September 25, 2006. http://business.highbeam.com/436989/article-1G1-151758768/revaprazan-yuhan-registered-south-korea.
 |  |
